Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H28N4O4 |
Molecular Weight | 412.4821 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCNC1=C2C(=O)C3=C(C(O)=CC=C3O)C(=O)C2=C(NCCN(C)C)C=C1
InChI
InChIKey=DBAMBJQJKDHEQX-UHFFFAOYSA-N
InChI=1S/C22H28N4O4/c1-25(2)11-9-23-13-5-6-14(24-10-12-26(3)4)18-17(13)21(29)19-15(27)7-8-16(28)20(19)22(18)30/h5-8,23-24,27-28H,9-12H2,1-4H3
Molecular Formula | C22H28N4O4 |
Molecular Weight | 412.4821 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:15:26 UTC 2023
by
admin
on
Fri Dec 15 17:15:26 UTC 2023
|
Record UNII |
QXB9LEJ2B2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
70476-63-0
Created by
admin on Fri Dec 15 17:15:26 UTC 2023 , Edited by admin on Fri Dec 15 17:15:26 UTC 2023
|
PRIMARY | |||
|
QXB9LEJ2B2
Created by
admin on Fri Dec 15 17:15:26 UTC 2023 , Edited by admin on Fri Dec 15 17:15:26 UTC 2023
|
PRIMARY | |||
|
DTXSID00220741
Created by
admin on Fri Dec 15 17:15:26 UTC 2023 , Edited by admin on Fri Dec 15 17:15:26 UTC 2023
|
PRIMARY | |||
|
135468
Created by
admin on Fri Dec 15 17:15:26 UTC 2023 , Edited by admin on Fri Dec 15 17:15:26 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
Reduction of AQ4N to the mono N-oxide intermediate AQ4M [ 1-{[2-(dimethylamino-N-oxide)ethyl]amino}-4-{[2-(dimethylamino) ethyl]amino}-5,8-dihydroxyanthracene-9,10-dione] and finally to AQ4 provides a mechanism for selectively generating the active topoisomerase inhibitor within hypoxic cancer cells.
|